Tiancen Biotech released its first quarter financial results, with a net profit attributable to the parent company of 455 million yuan, a decrease of 37.44%.

Intelligent Financial News App: Tongcheng Health (300146.SZ) released its first quarter report for 2025, with the company's operating income at 1.792 billion yuan, a decrease of 32.29% year-on-year. Net profit attributable to shareholders of the listed company was 455 million yuan, a decrease of 37.44% year-on-year. Net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 409 million yuan, a decrease of 42.36% year-on-year. Basic earnings per share was 0.27 yuan.